Hong Kong stocks surged | Zhongsheng Pharmaceutical (01177.HK) rose by over 5% again, with the company spending 500 million US dollars to acquire LiXin Medicine Further strengthening the layout of the oncology pipeline.

According to the Wisdom Finance and Economics APP, China Medicine Corporation (01177.HK) has surged by over 5% again, as of the time of publication, it has increased by 3.73% to 6.68 Hong Kong dollars, with a trading volume of 456 million Hong Kong dollars.